Improved Detection of Fibrotic Nonalcoholic Fatty Liver Disease in Community-Based Referrals
Authors:
- 15 November 2023
- journal article
- research article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 21 (9) , 475-478
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease with increasing rates globally. Patients with type 2 diabetes mellitus have higher risk of developing NAFLD. Patients with a higher degree of liver fibrosis in NAFLD are at an increased risk for liver-related mortality, but get missed easily during the referral process. This project aims to improve early detection and linkage-to-care of fibrotic NAFLD patients. Methods: We utilized a combination of automated electronic health record (EHR)-based fibrosis (FIB)-4 score and directed provider education. A health-system wide FIB-4 score calculator that providers can easily add to their workflow for NAFLD patient triaging. Data were analyzed at 6 and 12 months after implementation. Results: Postimplementation, there was an increase in patients referred to hepatology with higher degree of liver fibrosis and decreased referral to hepatology with low risk of liver fibrosis, measured by FIB-4 score. At baseline, ∼55% of referred patient to hepatology had FIB-4 score 1.3 when compared to preinterventions, 62% versus 45%. This is most pronounced in patients with severe fibrotic disease with FIB-4 score >2.67, 30% versus 12%. Conclusions: Automated FIB-4 score in EHR can improve appropriate linkage-to-care for at-risk fibrotic NAFLD, especially when coupled with targeted provider education. The durability of such improvement is essential to study along with the need to increase broad acceptance across health systems.Keywords
This publication has 11 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional RelationshipCanadian Journal of Gastroenterology and Hepatology, 2020
- Complications, morbidity and mortality of nonalcoholic fatty liver diseaseMetabolism, 2020
- The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)Journal of Diabetes Research, 2020
- NAFLD referral patterns in a large US academic centerJournal of Hepatology, 2020
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver diseaseJournal of Hepatology, 2019
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis StageClinical Gastroenterology and Hepatology, 2019
- NAFLD/NASH in patients with type 2 diabetes and related treatment optionsJournal of Endocrinological Investigation, 2017
- Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2017
- Management of NAFLD: a stage-based approachNature Reviews Gastroenterology & Hepatology, 2016
- FIB-4Hepatology, 2007